Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1840 1
1842 1
1843 1
1844 1
1847 1
1848 2
1857 1
1861 1
1862 1
1864 1
1870 1
1873 1
1876 1
1888 2
1889 1
1895 1
1898 2
1901 3
1903 1
1905 1
1907 1
1909 1
1911 1
1914 1
1916 1
1918 1
1921 2
1922 1
1927 1
1933 1
1934 1
1937 1
1938 3
1939 3
1940 1
1945 4
1946 15
1947 15
1948 6
1949 8
1950 8
1951 15
1952 10
1953 12
1954 6
1955 6
1956 10
1957 13
1958 11
1959 13
1960 12
1961 9
1962 17
1963 19
1964 11
1965 19
1966 10
1967 15
1968 24
1969 19
1970 19
1971 19
1972 15
1973 16
1974 17
1975 21
1976 23
1977 24
1978 42
1979 33
1980 31
1981 35
1982 46
1983 38
1984 28
1985 41
1986 61
1987 49
1988 53
1989 74
1990 70
1991 63
1992 68
1993 60
1994 62
1995 72
1996 78
1997 56
1998 77
1999 72
2000 89
2001 82
2002 87
2003 86
2004 73
2005 119
2006 87
2007 119
2008 133
2009 167
2010 151
2011 166
2012 241
2013 267
2014 277
2015 403
2016 400
2017 411
2018 453
2019 441
2020 489
2021 497
2022 512
2023 495
2024 181

Text availability

Article attribute

Article type

Publication date

Search Results

7,373 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Amberlee
Page 1
The Treasury of Wharton's Jelly.
Guenther R, Dreschers S, Maassen J, Reibert D, Skazik-Voogt C, Gutermuth A. Guenther R, et al. Stem Cell Rev Rep. 2022 Jun;18(5):1627-1638. doi: 10.1007/s12015-021-10217-8. Epub 2021 Oct 13. Stem Cell Rev Rep. 2022. PMID: 34647276 Free PMC article.
Wharton's Jelly stem cells: future clinical applications.
Taghizadeh RR, Cetrulo KJ, Cetrulo CL. Taghizadeh RR, et al. Placenta. 2011 Oct;32 Suppl 4:S311-5. doi: 10.1016/j.placenta.2011.06.010. Epub 2011 Jul 6. Placenta. 2011. PMID: 21733573 Review.
This review focuses on the therapeutic potential of stem cells harvested from the Wharton's Jelly of the human umbilical cord. Recently, investigators have found that a potent stem cell population exists within the Wharton's Jelly. ...Current evidence …
This review focuses on the therapeutic potential of stem cells harvested from the Wharton's Jelly of the human umbilical cord. …
Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM.
Kassem DH, Kamal MM. Kassem DH, et al. Trends Endocrinol Metab. 2020 Apr;31(4):271-273. doi: 10.1016/j.tem.2020.01.001. Epub 2020 Feb 5. Trends Endocrinol Metab. 2020. PMID: 32035737 Review.
Stem cell therapy provides great hope to all diabetic patients. Umbilical cord (UC) Wharton's jelly mesenchymal stem cells (WJ-MSCs) specifically provides a potential cell therapy for DM. ...
Stem cell therapy provides great hope to all diabetic patients. Umbilical cord (UC) Wharton's jelly mesenchymal stem cells (WJ …
Absence of Wharton's jelly.
Murphy SJ, Deegan N, O'Leary BD, McParland P. Murphy SJ, et al. BMJ Case Rep. 2020 Nov 30;13(11):e237222. doi: 10.1136/bcr-2020-237222. BMJ Case Rep. 2020. PMID: 33257379 Free PMC article.
Wharton's jelly is a specialised tissue which surrounds the vasculature within the fetal umbilical cord. We present the case of a 42-year-old woman who gave birth to a female infant via emergency caesarean section. At the time of delivery, absence of Wharton'
Wharton's jelly is a specialised tissue which surrounds the vasculature within the fetal umbilical cord. We present the case o
Umbilical Cord-Derived Wharton's Jelly for Regenerative Medicine Applications: A Systematic Review.
Main BJ, Maffulli N, Valk JA, Rodriguez HC, Gupta M, El-Amin SF 3rd, Gupta A. Main BJ, et al. Pharmaceuticals (Basel). 2021 Oct 27;14(11):1090. doi: 10.3390/ph14111090. Pharmaceuticals (Basel). 2021. PMID: 34832872 Free PMC article. Review.
Mesenchymal stem cells (MSCs) have emerged as an exciting therapeutic alternative and Wharton's jelly-derived mesenchymal stem cells (WJSCs) are some of these. ...The studies that used culture-expanded, mesenchymal stem or stromal cells, MSCs and/or connective tissu …
Mesenchymal stem cells (MSCs) have emerged as an exciting therapeutic alternative and Wharton's jelly-derived mesenchymal stem …
Pericytes in the Umbilical Cord.
Gauthier-Fisher A, Szaraz P, Librach CL. Gauthier-Fisher A, et al. Adv Exp Med Biol. 2019;1122:211-233. doi: 10.1007/978-3-030-11093-2_12. Adv Exp Med Biol. 2019. PMID: 30937871 Review.
The structural components of the umbilical cord, including two arteries and one vein, the stromal region/Wharton's jelly, and amniotic epithelial membrane, are well described at various time points of gestation. Over the last two decades, evidence has emerged that m …
The structural components of the umbilical cord, including two arteries and one vein, the stromal region/Wharton's jelly, and …
Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation.
Pochon C, Notarantonio AB, Laroye C, Reppel L, Bensoussan D, Bertrand A, Rubio MT, D'Aveni M. Pochon C, et al. J Cell Mol Med. 2022 Mar;26(5):1339-1350. doi: 10.1111/jcmm.17105. Epub 2022 Jan 28. J Cell Mol Med. 2022. PMID: 35088933 Free PMC article. Review.
Postnatally derived MSCs seem to be of particular interest because they are harvested after delivery without ethical controversy, they have the capacity to expand at a higher rate than adult-derived MSCs, in which expansion decreases with ageing, and they have demonstrated immuno …
Postnatally derived MSCs seem to be of particular interest because they are harvested after delivery without ethical controversy, they have …
Wharton's jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications.
Drobiova H, Sindhu S, Ahmad R, Haddad D, Al-Mulla F, Al Madhoun A. Drobiova H, et al. Front Cell Dev Biol. 2023 Jun 27;11:1211217. doi: 10.3389/fcell.2023.1211217. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37440921 Free PMC article. Review.
Accumulating evidence indicates that most primary Wharton's jelly mesenchymal stem cells (WJ-MSCs) therapeutic potential is due to their paracrine activity, i.e., their ability to modulate their microenvironment by releasing bioactive molecules and factors collectiv …
Accumulating evidence indicates that most primary Wharton's jelly mesenchymal stem cells (WJ-MSCs) therapeutic potential is du …
Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid.
Joerger-Messerli MS, Marx C, Oppliger B, Mueller M, Surbek DV, Schoeberlein A. Joerger-Messerli MS, et al. Best Pract Res Clin Obstet Gynaecol. 2016 Feb;31:30-44. doi: 10.1016/j.bpobgyn.2015.07.006. Epub 2015 Sep 10. Best Pract Res Clin Obstet Gynaecol. 2016. PMID: 26482184 Review.
The discovery of mesenchymal stem cells (MSCs) in perinatal sources, such as the amniotic fluid (AF) and the umbilical connective tissue, the so-called Wharton's jelly (WJ), has transformed them into promising stem cell grafts for the application in regenerative med …
The discovery of mesenchymal stem cells (MSCs) in perinatal sources, such as the amniotic fluid (AF) and the umbilical connective tissue, th …
Human Wharton's Jelly-Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials.
Stefańska K, Ożegowska K, Hutchings G, Popis M, Moncrieff L, Dompe C, Janowicz K, Pieńkowski W, Gutaj P, Shibli JA, Prado WM, Piotrowska-Kempisty H, Mozdziak P, Bruska M, Zabel M, Kempisty B, Nowicki M. Stefańska K, et al. J Clin Med. 2020 Apr 12;9(4):1102. doi: 10.3390/jcm9041102. J Clin Med. 2020. PMID: 32290584 Free PMC article. Review.
Moreover, Wharton's jelly-derived MSCs (WJ-MSCs) do not express MHC-II and exhibit immunomodulatory properties, which makes them a good alternative for allogeneic and xenogeneic transplantations in cellular therapies. Therefore, umbilical cord, especially Wharton
Moreover, Wharton's jelly-derived MSCs (WJ-MSCs) do not express MHC-II and exhibit immunomodulatory properties, which makes th …
7,373 results